Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial).

Hiroko MinatogawaNaoki IzawaKazuhiro ShimomuraHitoshi AriokaHirotoshi IiharaMitsuhiro SugawaraHajime MoritaAyako MochizukiShuichi NawataKeisuke MishimaAyako TsuboyaTempei MiyajiKazunori HondaAyako YokomizoNaoya HashimotoTakeshi YanagiharaJunki EndoTakashi KawaguchiNaoki FuruyaYumiko SoneYusuke InadaYasushi OhnoChikatoshi KatadaNaoya HidaKana AkiyamaDaisuke IchikuraAkiko KonomatsuTakashi OguraTakuhiro YamaguchiTakako Eguchi Nakajima

Published in: British journal of cancer (2023)

UMIN000032269.

Keyphrases

phase iii
open label
clinical trial
phase ii
double blind
placebo controlled
low dose
chemotherapy induced
study protocol
neuropathic pain
robot assisted
spinal cord injury